Search research articles
Contact Us
Filters
Showing results (121-130 of 185) with videos related to
Page
of 19
Sort By:
Clinical Pharmacology and Therapeutics
|
July 7, 2022
Comparative Pharmacokinetics of Tixagevimab/Cilgavimab (AZD7442) Administered Intravenously Versus Intramuscularly in Symptomatic SARS-CoV-2 Infection
Rachel A Bender Ignacio, David A Wohl, Rosalin Arends, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 19, 2022
Viral and Symptom Rebound in Untreated COVID-19 Infection
Rinki Deo, Manish C Choudhary, Carlee Moser, et al.
PLOS Global Public Health
|
March 27, 2023
It takes more than a machine: A pilot feasibility study of point-of-care HIV-1 viral load testing at a lower-level health center in rural western Uganda
Ross M Boyce, Ronnie Ndizeye, Herbert Ngelese, et al.
AIDS (London, England)
|
December 20, 2015
Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b study
Jan van Lunzen, Andrea Antinori, Calvin J Cohen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 10, 2017
Randomized Controlled Trial of an Intervention to Maintain Suppression of HIV Viremia After Prison Release: The imPACT Trial
David A Wohl, Carol E Golin, Kevin Knight, et al.
The Journal of Infectious Diseases
|
October 14, 2024
Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial
Kara W Chew, Brooke McGinley, Carlee Moser, et al.
Eclinicalmedicine
|
September 10, 2024
Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial
Teresa H Evering, Carlee Moser, Nikolaus Jilg, et al.
AIDS Research and Human Retroviruses
|
March 13, 2020
Participant Perspectives in an HIV Cure-Related Trial Conducted Exclusively in Women in the United States: Results from AIDS Clinical Trials Group 5366
Karine Dubé, Lara Hosey, Kate Starr, et al.
AIDS Research and Human Retroviruses
|
October 15, 2019
The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy
Karine Dubé, Shadi Eskaf, David Evans, et al.
The Journal of Infectious Diseases
|
April 17, 2018
Anti-Ebola Virus Antibody Levels in Convalescent Plasma and Viral Load After Plasma Infusion in Patients With Ebola Virus Disease
Jerry F Brown, John M Dye, Sam Tozay, et al.
Page
of 19
Search research articles
Search
Showing results (121-130 of 185) with videos related to
Sort By:
Page
of 19
Clinical Pharmacology and Therapeutics
|
July 7, 2022
Comparative Pharmacokinetics of Tixagevimab/Cilgavimab (AZD7442) Administered Intravenously Versus Intramuscularly in Symptomatic SARS-CoV-2 Infection
Rachel A Bender Ignacio, David A Wohl, Rosalin Arends, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 19, 2022
Viral and Symptom Rebound in Untreated COVID-19 Infection
Rinki Deo, Manish C Choudhary, Carlee Moser, et al.
PLOS Global Public Health
|
March 27, 2023
It takes more than a machine: A pilot feasibility study of point-of-care HIV-1 viral load testing at a lower-level health center in rural western Uganda
Ross M Boyce, Ronnie Ndizeye, Herbert Ngelese, et al.
AIDS (London, England)
|
December 20, 2015
Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b study
Jan van Lunzen, Andrea Antinori, Calvin J Cohen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 10, 2017
Randomized Controlled Trial of an Intervention to Maintain Suppression of HIV Viremia After Prison Release: The imPACT Trial
David A Wohl, Carol E Golin, Kevin Knight, et al.
The Journal of Infectious Diseases
|
October 14, 2024
Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial
Kara W Chew, Brooke McGinley, Carlee Moser, et al.
Eclinicalmedicine
|
September 10, 2024
Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial
Teresa H Evering, Carlee Moser, Nikolaus Jilg, et al.
AIDS Research and Human Retroviruses
|
March 13, 2020
Participant Perspectives in an HIV Cure-Related Trial Conducted Exclusively in Women in the United States: Results from AIDS Clinical Trials Group 5366
Karine Dubé, Lara Hosey, Kate Starr, et al.
AIDS Research and Human Retroviruses
|
October 15, 2019
The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy
Karine Dubé, Shadi Eskaf, David Evans, et al.
The Journal of Infectious Diseases
|
April 17, 2018
Anti-Ebola Virus Antibody Levels in Convalescent Plasma and Viral Load After Plasma Infusion in Patients With Ebola Virus Disease
Jerry F Brown, John M Dye, Sam Tozay, et al.
Page
of 19